Background pattern

DIAVIC 6 mg/ml INJECTABLE SOLUTION IN PRE-FILLED PEN

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DIAVIC 6 mg/ml INJECTABLE SOLUTION IN PRE-FILLED PEN

Introduction

Package Leaflet: Information for the Patient

Diavic 6 mg/ml Solution for Injection in Pre-filled Pen EFG

Liraglutide

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Diavic and what is it used for
  2. What you need to know before you start using Diavic
  3. How to use Diavic
  4. Possible side effects
  5. Storage of Diavic
  6. Contents of the pack and further information

1. What is Diavic and what is it used for

Diavic contains the active substance liraglutide. It helps your body to reduce your blood sugar level only when your blood sugar level is too high. It also slows down the movement of food from your stomach and may help to prevent heart disease.

Liraglutide is used on its own if your blood sugar level is not controlled by diet and exercise alone, and you cannot use metformin (another diabetes medicine).

Liraglutide is used together with other diabetes medicines when these are not enough to control your blood sugar level. These may include:

  • oral anti-diabetics (such as metformin, pioglitazone, sulfonylurea, sodium-glucose cotransporter type 2 (SGLT2) inhibitor) and/or insulin.

2. What you need to know before you use Diavic

Do not use Diavic

  • If you are allergic to liraglutide or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse:

  • before you start using liraglutide.
  • if you have or have had pancreatitis.

If you are going to have an operation, tell your doctor that you are using Diavic.

This medicine should not be used if you have type 1 diabetes (your body does not produce any insulin) or diabetic ketoacidosis (a complication of diabetes characterized by high blood sugar levels and increased breathing rate). It is not an insulin and should not be used as a substitute for insulin.

Diavic should not be used if you are on dialysis.

Diavic should not be used if you have severe liver disease.

The use of Diavic is not recommended if you have severe heart failure.

This medicine should not be used if you have a severe stomach or intestinal problem that causes delayed emptying of the stomach (called gastroparesis) or inflammatory bowel disease.

If you get symptoms of acute pancreatitis, such as severe and persistent stomach pain, you should contact your doctor immediately (see section 4).

If you have thyroid disease, including thyroid nodules and increased thyroid gland size, talk to your doctor.

When you start using Diavic, you may experience dehydration (loss of fluids), for example, if you have vomiting, nausea, and diarrhea. It is important to avoid dehydration by drinking plenty of fluids. Talk to your doctor if you have any questions.

Children and adolescents

Diavic can be used in adolescents and children from 10 years of age. There is no data available in children under 10 years of age.

Other medicines and Diavic

Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use any other medicines.

In particular, tell your doctor, pharmacist, or nurse if you are using medicines that contain any of the following active substances:

  • Sulfonylurea (such as glimepiride or glibenclamide) or insulin. You may experience hypoglycemia (low blood sugar) when using Diavic with a sulfonylurea or insulin, as sulfonylureas and insulin increase the risk of hypoglycemia. When you start using these medicines together for the first time, your doctor may tell you to reduce the dose of sulfonylurea or insulin. To see the warning signs of low blood sugar, see section 4. If you are also taking a sulfonylurea (such as glimepiride or glibenclamide) or insulin, your doctor may ask you to have your blood sugar levels checked. This will help your doctor decide if it is necessary to change the dose of sulfonylurea or insulin.
  • If you are taking insulin, your doctor will tell you how to reduce the dose of insulin and recommend that you check your blood sugar level more frequently to avoid hyperglycemia (high blood sugar) and diabetic ketoacidosis (a complication of diabetes that occurs when the body cannot break down glucose because there is not enough insulin).
  • Warfarin or other anticoagulant medicines. You may need to have more frequent blood tests to check your blood clotting.

Pregnancy and breastfeeding

Tell your doctor if you are pregnant, think you may be pregnant, or are planning to have a baby. Diavic should not be used during pregnancy because it is not known if it could harm the baby.

It is not known if liraglutide passes into breast milk, so do not use this medicine during breastfeeding.

Driving and using machines

Low blood sugar (hypoglycemia) can reduce your ability to concentrate. Avoid driving or using machines if you experience symptoms of hypoglycemia. See section 4 for the warning signs of low blood sugar. Talk to your doctor for more information.

Important information about some of the ingredients of Diavic

This medicine contains less than 1 mmol of sodium (23 mg) per dose, which is essentially "sodium-free".

3. How to use Diavic

Follow the instructions for administration of this medicine exactly as told by your doctor. If you are not sure, ask your doctor, pharmacist, or nurse.

  • The initial dose is 0.6 mg once a day for at least 1 week.
  • Your doctor will tell you when to increase the dose to 1.2 mg once a day.
  • Your doctor may tell you to further increase the dose to 1.8 mg once a day if your blood sugar is not controlled with a dose of 1.2 mg.

Do not change the dose unless your doctor tells you to.

Diavic is given as an injection under the skin (subcutaneously). Do not inject into a vein or muscle. The best injection sites are the front of the thigh, the abdomen, or the upper arm. Change the injection site each day to reduce the risk of developing lumps under the skin. You can inject at any time of day, with or without food. Once you have decided on the best time of day for you, it is best to inject Diavic at the same time each day.

Before using the pen for the first time, your doctor or nurse will show you how to use it.

On the other side of this leaflet, you will find detailed instructions on how to use it.

If you use more Diavic than you should

If you use more Diavic than you should, talk to your doctor immediately. You can also call the Toxicology Information Service, phone 91 562 04 20, stating the medicine and the amount taken. You may need medical treatment. You may experience nausea, vomiting, diarrhea, or low blood sugar (hypoglycemia). See the warning signs of low blood sugar in section 4.

If you forget to use Diavic

If you forget a dose, use Diavic as soon as you remember.

However, if it is more than 12 hours since you should have used Diavic, skip the missed dose. Give the next dose at the usual time the next day.

Do not use a double dose or increase the dose the next day to make up for the missed dose.

If you stop using Diavic

Do not stop using Diavic without talking to your doctor. If you stop, your blood sugar levels may increase.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

Common: may affect up to 1 in 10 people

  • Hypoglycemia (low blood sugar). The warning signs of low blood sugar may appear suddenly and include: cold sweat, cool pale skin, headache, fast heartbeat, nausea, excessive hunger, vision problems, drowsiness, feeling weak, nervousness, anxiety, confusion, difficulty concentrating, and shakiness. Your doctor will tell you how to treat low blood sugar and what to do if you notice these warning signs. This is more likely to happen if you are also using a sulfonylurea or insulin. Your doctor may reduce your dose of these medicines before you start using Diavic.

Rare: may affect up to 1 in 1,000 people

  • A severe allergic reaction (anaphylactic reaction) with additional symptoms such as breathing problems, swelling of the throat and face, fast heartbeat, etc. If you notice any of these symptoms, seek medical help immediately and talk to your doctor as soon as possible.
  • Intestinal obstruction. A severe form of constipation with additional symptoms such as stomach pain, bloating, vomiting, etc.

Very rare: may affect up to 1 in 10,000 people

  • Cases of pancreatitis (inflammation of the pancreas). Pancreatitis can be a serious and potentially life-threatening disease. Stop using Diavic and contact your doctor immediately if you notice any of the following serious side effects:

Severe and persistent stomach pain (in the abdomen) that may radiate to the back, as well as nausea and vomiting, as this could be a sign of pancreatitis.

Other side effects

Very common: may affect more than 1 in 10 people

  • Nausea (feeling sick). This side effect usually goes away over time.
  • Diarrhea. This side effect usually goes away over time.

Common: may affect up to 1 in 10 people

  • Vomiting

When you start using liraglutide, you may experience loss of fluids/dehydration, for example, if you have vomiting, nausea, and diarrhea. It is important to avoid dehydration by drinking plenty of fluids.

  • Headache
  • Indigestion
  • Stomach inflammation (gastritis). The symptoms include stomach pain, nausea, and vomiting.
  • Gastroesophageal reflux disease (GERD). The symptoms include heartburn.
  • Bloated stomach (abdomen) or stomach pain
  • Abdominal discomfort
  • Constipation
  • Gas (flatulence)
  • Decreased appetite
  • Bronchitis
  • Common cold
  • Dizziness
  • Fast heartbeat
  • Fatigue
  • Toothache
  • Injection site reactions (bruising, pain, irritation, itching, and rash)
  • Increased pancreatic enzymes (such as lipase and amylase).

Uncommon: may affect up to 1 in 100 people

  • Allergic reactions such as itching (pruritus) and hives (urticaria)
  • Dehydration, sometimes with decreased kidney function
  • Feeling unwell
  • Gallstones
  • Inflamed gallbladder
  • Change in taste
  • Delayed gastric emptying.

Frequency not known (cannot be estimated from the available data):

  • Lumps under the skin can occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis; the frequency of this is not known).

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Diavic

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and on the pen after EXP. The expiry date is the last day of the month stated.

Before use:

Store in a refrigerator (2°C–8°C). Do not freeze. Keep away from the freezer.

During use:

You can store the pen for a month if it is stored below 30 °C or in a refrigerator (between 2 °C and 8 °C), away from the freezer. Do not freeze.

When not in use, store the pen with the cap on to protect it from light.

Do not use this medicine if you notice that the solution is not clear and colorless or almost colorless.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Diavic

  • The active ingredient is liraglutide. 1 ml of injectable solution contains 6 mg of liraglutide. A pre-filled pen contains 18 mg of liraglutide.
  • The other components are sodium dihydrogen phosphate, propylene glycol (E1520), phenol, sodium hydroxide (for pH adjustment), concentrated hydrochloric acid (for pH adjustment), and water for injectable preparations.

Appearance and packaging of the product

Diavic is a clear and colorless or almost colorless solution, supplied with a pre-filled pen. It consists of a plunger with a bromobutyl rubber stopper and a colorless glass cartridge type I assembled in a pen-type injector, with a light blue body subset with a light blue button and a yellow dose adjustment knob with a gray cap. Each pen contains 3 ml of solution, which can deliver 30 doses of 0.6 mg, 15 doses of 1.2 mg, or 10 doses of 1.8 mg.

Diavic is available in packs of 1, 2, 3, 5, 10, or a multipack with 10 (2 packs of 5) pens.

Only some pack sizes may be marketed.

Needles are not included.

Marketing authorization holder and manufacturer

Marketing authorization holder

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe

Sun Pharmaceutical Industries Europe B.V.

Polarisavenue 87

2132JH, Hoofddorp

Netherlands

Manufacturer

Sun Pharmaceutical Industries Europe B.V.

Polarisavenue 87

2132JH, Hoofddorp

Netherlands

or

Terapia SA

124 Fabricii Street,

400632, Cluj-Napoca,

Romania

You can request more information about this medicine by contacting the local representative of the marketing authorization holder:

Sun Pharma Laboratories, S.L.

Rambla de Catalunya 53-55

08007-Barcelona

Spain

Tel: + 34-93-3427890

This medicine is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Germany: DIAVIC 6 mg/ml Injektionslösung in einem Fertigpen

Spain: DIAVIC 6 mg/ml solución inyectable en pluma precargada EFG

Finland: DIAVIC 6 mg/ml injektioneste, liuos, esitäytetty kynä

France: Liraglutide Sun 6 mg/ml solution injectable en stylo prérempli

Italy: DIAVIC

Netherlands: Diavic 6 mg/ml oplossing voor injectie in een voorgevulde pen

Poland: DIAVIC

Romania: DIAVIC 6 mg/ml solutie injectabila în stilou injector (pen) preumplut

Sweden: DIAVIC 6 mg/ml injektionsvätska, lösning i förfylld injektionspenna or

You can request more information about this medicine by contacting the local representative of the marketing authorization holder:

Sun Pharma Laboratories, S.L.

Rambla de Catalunya 53-55

08007 Barcelona

Spain

Tel: +34-93-3427890

Date of the last revision of the leaflet: May 2025

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

INSTRUCTIONS FOR USE OF THE DIAVIC PEN

Read these instructions carefully before using your pen.

Your pen contains 18 mg of liraglutide. You can select doses of 0.6 mg, 1.2 mg, or 1.8 mg.

The pen is designed to be used with disposable injection needles with a length of up to 8 mm and as thin as 32G (0.25/0.23 mm).

Injector pen with viewfinder, dose selector, and indicator, cartridge with scale, needle, and inner and outer capsYellow symbol of a conduit with an inverted U and a line below indicating the flow of the medicine

Preparation of the pen

Check the name and color of the labelon your pen to ensure it contains liraglutide. Using the wrong medicine could cause serious harm.

Remove the pen cap.

Hand holding a blue auto-injector with a red arrow indicating the direction of injection into the skin

Remove the paper tab from a new disposable needle. Screw the needle straight and firmly onto the pen.

Hand holding an injection device with a connected needle and a red arrow indicating the direction of insertion

Remove the outer needle cap and set it aside for later use.

Connection of two cylindrical syringe components with a red arrow indicating the direction of connection

Remove the inner needle cap and discard it.

Syringe with needle inserted into the skin, red arrow indicates direction of injection, hand holding the device

Always use a new needle for each injection. This reduces the risk of contamination, infection, loss of liraglutide, needle blockage, and inaccurate dosing.

Be careful not to bend or damage the needle.

Never try to put the inner needle cap back on. You could prick yourself with the needle.

Maintenance of your pen

  • Do not attempt to repair the pen or disassemble it.
  • Keep the pen away from dust, dirt, and all types of liquids.
  • Clean the pen with a damp cloth and mild detergent.
  • Do not try to wash, submerge, or lubricate it; this may damage the pen.

Important information

  • Do not share your pen or needles with anyone else.
  • Keep your pen out of the reach of others, especially children.

Check the flow with each new pen

Check the flow before the first injection with each new pen. If your pen is already in use, go to 'Dose selection', step H.

Turn the dose selector until the indicator points to the flow selection symbol.

Hands holding an injection device with a flow verification window and a red arrow indicating direction

Hold the pen with the needle pointing upwards. Tap the cartridge gently with your finger several times. This will concentrate any air bubbles in the top of the cartridge.

Syringe with needle inserted into the skin showing a small elevation or skin fold with curved lines

Hold the needle pointing upwards and press the push button until the indicator points to 0 mg.

A drop of liraglutide should appear at the tip of the needle. If no drop appears, repeat steps Eto Gup to four times.

If still no drop of liraglutide appears, change the needle and repeat steps Eto Gonce more.

Do not use the pen if a drop of liraglutide still does not appear. This indicates that the pen is defective and you should use a new one.

Hand holding a blue and yellow auto-injector with a red arrow indicating direction and a small diagram of an internal mechanism

If the pen has been dropped onto a hard surface or you suspect it is not working correctly, always put a new disposable needle on and check the flow before using it.

Dose selection

Always check that the indicator points to 0 mg.

Turn the dose selector until the indicator points to the required dose (0.6 mg, 1.2 mg, or 1.8 mg).

If you accidentally select the wrong dose, to change it simply turn the dose selector backwards or forwards until the indicator points to the correct dose.

Be careful not to press the injection button while turning the dose selector backwards, as liraglutide may be released.

If the dose selector stops before the indicator points to the required dose, this means there is not enough liraglutide left for a full dose. In this case, you can:

Divide your dose into two injections:

Turn the dose selector in any direction until the indicator points to 0.6 mg or 1.2 mg. Inject the dose. Then prepare a new pen and inject the remaining number of mg to complete your dose.

You should only divide your dose between the current pen and a new pen if you have received proper training or advice from your healthcare professional. Use a calculator to plan your doses. If you divide the dose incorrectly, you may inject too much or too little liraglutide.

Inject the full dose with a new pen:

If the dose selector stops before the indicator points to 0.6 mg, prepare a new pen and inject the full dose with it.

Injection device with selected doses of 0.6mg, 1.2mg, and 1.8mg shown with red arrows indicating dose adjustment

Do not attempt to select doses other than 0.6 mg, 1.2 mg, or 1.8 mg. The numbers on the

viewfinder must be exactly aligned with the indicator to ensure you receive the correct dose.

You will hear a click each time you turn the dose selector. Do not use these clicks to select your dose.

Do not use the cartridge scale to measure the amount of liraglutide to be injected, as it is not accurate enough.

Injection of the dose

Insert the needle under the skin using the injection technique recommended by your doctor or nurse.Then follow these instructions:

Press the push button until the indicator points to 0 mg. Be careful not to touch the viewfinder with your other fingers or press the dose selector from the side while injecting, as this may block the injection. Hold the push button down and keep the needle under the skin for at least 6 seconds. This ensures that the full dose is administered.

Blue and yellow auto-injector device held by a hand with a red arrow indicating pressure and a window showing zero dose

Remove the needle.

You may see a drop of liraglutide at the tip of the needle.

This is normal and does not affect your dose.

Transparent syringe with liquid and needle inserted into beige skin with a red arrow indicating direction

Insert the needle tip into the outer needle cap without touching the needle or the outer needle cap.

Needle connecting to the syringe with a red arrow indicating the direction of connection and assembly

When the needle is protected, carefully press the outer needle cap down to the end. Then unscrew the needle. Carefully dispose of the needle and replace the pen cap.

When the pen is empty, carefully dispose of it without any needle attached. Please dispose of the pen and needle according to local regulations.

Hand holding a syringe with a needle inserted into the skin, red arrow indicates direction of injection

Always remove the needle after each injection and store your pen with the needle attached.

This reduces the risk of contamination, infection, loss of liraglutide, needle blockage, and inaccurate dosing.

People caring for patients should be very careful when handling used needles to avoid accidental pricks or infections.